B.R.A.I.N. Biotechnology Research And Information Network AG (ETR:DE000520) | WebDisclosure

Basculer en Français

10355	Companies
215468	Keywords
145294	Articles
114152	Press releases

Headlines Articles Press releases B.R.A.I.N. Biotechnology Research And Information Network AG

Home
Companies
B.R.A.I.N. Biotechnology Research And Information Network AG

PRESS RELEASE

published on 10/31/2024 at 19:20, 1 year 6 months ago

BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology
BRAIN Biotech AG signs exclusive pharma licensing agreement with Akribion Therapeutics GmbH for G-dase E(R) CRISPR-Cas technology, offering up to EUR 92.3 million R&D and commercial milestone fees along with royalties

BRAIN Biotech AG CRISPR-Cas Technology Pharma Licensing Agreement Akribion Therapeutics GmbH G-dase E(R)
BRIEF

published on 10/31/2024 at 19:16, 1 year 6 months ago

BRAIN Biotech AG Secures Licensing Deal with Akribion Therapeutics

Royalties Biotech Licensing CRISPR-Cas Technology Pharma Agreement Milestone Fees
BRIEF

published on 10/31/2024 at 19:16, 1 year 6 months ago

BRAIN Biotech AG conclut un accord de licence avec Akribion Therapeutics

Redevance Licences Biotechnologiques Technologie CRISPR-Cas Accord Pharmaceutique Frais D'étape
PRESS RELEASE

published on 10/31/2024 at 19:11, 1 year 6 months ago

EQS-Adhoc: BRAIN Biotech AG signs exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology with Akribion Therapeutics GmbH for up to EUR 92.3 million milestone fees plus royalties
BRAIN Biotech AG signs exclusive pharma licensing agreement with Akribion Therapeutics GmbH for G-dase E® CRISPR-Cas technology, potentially receiving up to EUR 92.3 million milestone fees and royalties

BRAIN Biotech AG CRISPR-Cas Technology Pharma Licensing Agreement Akribion Therapeutics GmbH G-dase E®
BRIEF

published on 10/03/2024 at 14:05, 1 year 7 months ago

Prof. Dr. Wiltrud Treffenfeldt Steps Down from BRAIN Biotech AG Supervisory Board

Biotechnology Resignation Supervisory Board BRAIN Biotech AG Wiltrud Treffenfeldt
BRIEF

published on 10/03/2024 at 14:05, 1 year 7 months ago

Le professeur Wiltrud Treffenfeldt quitte le conseil de surveillance de BRAIN Biotech AG

Biotechnologie Démission Conseil De Surveillance BRAIN Biotech SA Wiltrud Treffenfeldt
PRESS RELEASE

published on 10/03/2024 at 14:00, 1 year 7 months ago

Prof. Dr. Wiltrud Treffenfeldt leaves Supervisory Board of BRAIN Biotech AG for personal reasons
Prof. Dr. Wiltrud Treffenfeldt resigns from Supervisory Board of BRAIN Biotech AG for personal reasons. Search for successor initiated. Company specializes in industrial biotechnology solutions

Biotechnology Resignation Supervisory Board Successor BRAIN Biotech AG
BRIEF

published on 09/20/2024 at 19:55, 1 year 7 months ago

BRAIN Biotech AG Secures EUR 128.88 Million Deal with Royalty Pharma

Non-dilutive Financing BRAIN Biotech AG Royalty Monetization Investigational Compound Industrial Enzymes
BRIEF

published on 09/20/2024 at 19:55, 1 year 7 months ago

BRAIN Biotech AG conclut un accord de 128,88 millions d'euros avec Royalty Pharma

BRAIN Biotech SA Financement Non Dilutif Monétisation Des Redevances Composé Expérimental Enzymes Industrielles
BRIEF

published on 09/20/2024 at 19:52, 1 year 7 months ago

BRAIN Biotech AG Secures Royalty Monetization Deal Worth Up to EUR 128.88 Million

BRAIN Biotech Royalty Monetization Deucrictibant Royalty Pharma Hereditary Angioedema

Accesswire

Published on 05/06/2026 at 18:35, 2 hours 24 minutes ago

CoTec to Form an Early Stage Exploration Joint Venture with U.S. Company Copper Intelligence to Target Processing Historical Copper Tailings Opportunities in the Democratic Republic of Congo
Published on 05/06/2026 at 16:30, 4 hours 29 minutes ago

Silver Spruce Resources Inc. Announces Results of Annual and Special Meeting of Shareholders
Published on 05/06/2026 at 15:25, 5 hours 34 minutes ago

Electrovaya Announces Date for Q2-2026 Financial Results & Conference Call
Published on 05/06/2026 at 15:15, 5 hours 44 minutes ago

Karbon-X Reports Increased Engagement as Canadian Facilities Reassess Compliance Exposure Ahead of Carbon Deadlines
Published on 05/06/2026 at 15:12, 5 hours 47 minutes ago

Revival Gold Announces Closing of $33 Million Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 05/06/2026 at 20:32, 27 minutes ago

EQS-Adhoc: Kontron AG: ADHOC Kontron AG / Potential Public Takeover Bid by Ennoconn Corporation
Published on 05/06/2026 at 20:22, 37 minutes ago

EQS-Adhoc: ams-OSRAM AG: ams OSRAM delivers strong Q1 results, enters AI market through a development agreement with a leading AI photonics customer and sees path to positive Free Cash Flow in 2027
Published on 05/06/2026 at 19:18, 1 hour 41 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/06/2026 at 18:47, 2 hours 11 minutes ago

Amadeus Fire Group starts the current year on a positive note and confirms the forecast for the financial year 2026
Published on 05/06/2026 at 18:30, 2 hours 29 minutes ago

Avolta shareholders approve all proposals of the Board at the Ordinary General Meeting 2026

Les Echos

Published on 05/06/2026 at 18:00, 2 hours 59 minutes ago

Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 2 hours 59 minutes ago

Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 2 hours 59 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 18:00, 2 hours 59 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026
Published on 05/06/2026 at 17:45, 3 hours 14 minutes ago

Information concerning the total number of voting rights and shares 2026 04 30

View all LES ECHOS COMFI WIRE